CyberKnife stereotactic ablative radiotherapy (SABR) in patients with non-small cell lung cancer ( NSCLC)

被引：0
|
作者：
Leschenko, Y. [1 ]
Chebotareva, T. [1 ]
Spizhenko, N. [1 ]
Fedusenko, A. [1 ]
Sharaevskiy, O. [1 ]
Buryk, V. [1 ]
机构：
[1] Cyber Knife, Cyber Clin Spizhenko, Kapitanivka, Kyiv Region, Ukraine
来源：
RADIOTHERAPY AND ONCOLOGY | 2014年 / 111卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-1155
引用
收藏
页码：S39 / S39
页数：1
相关论文
共 50 条
  • [11] Lobectomy versus Stereotactic Ablative Radiotherapy (SABR) for Stage I Non Small Cell Lung Cancer (NSCLC) in 182 Patients
    Scotti, Vieri
    Simontacchi, Gabriele
    Furfaro, Ilaria Francesca
    Scartoni, Daniele
    Gonfiotti, Alessandro
    Viggiano, Domenico
    Cardillo, Carla De Luca
    Ferrari, Katia
    Agresti, Benedetta
    Zei, Giacomo
    Perna, Marco
    Bastiani, Paolo
    Bruni, Alessio
    Voltolini, Luca
    Livi, Lorenzo
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S675 - S675
  • [12] Curative Treatment Rates and Use of Stereotactic Ablative Radiotherapy (SABR) for Stage I Non-small Cell Lung Cancer (NSCLC) in England
    Harden, S.
    CLINICAL ONCOLOGY, 2018, 30 (06) : E50 - E50
  • [13] Audit of radiotherapy plan quality for stereotactic ablative radiotherapy (SABR) for stage 1 non-small cell lung cancer
    Pascoe, A. C.
    Foweraker, K.
    Esler, C.
    Morgan, S.
    Wallace, A.
    Launders, D.
    Harron, E.
    CLINICAL ONCOLOGY, 2016, 28 : S4 - S4
  • [14] Stereotactic ablative radiotherapy ( SABR) for non-small cell lung cancer (NSCLC): analysis of T3N0M0 patients
    Pickles, R.
    Atherton, P.
    Turnbull, H.
    Burns, A.
    Iqbal, M. S.
    LUNG CANCER, 2020, 139 : S31 - S31
  • [15] Accelerated hypofractionated intensity modulated radiotherapy (IMRT) for early stage non-small cell lung cancer (NSCLC) in patients not suitable for conventional stereotactic ablative radiotherapy (SABR)
    Lavin, V.
    Whitehurst, P.
    Harris, C.
    Goldstraw, R.
    Bayman, N.
    Chan, C.
    Coote, J.
    Harris, M.
    Pemberton, L.
    Sheikh, H.
    Woolf, D.
    Faivre-Finn, C.
    LUNG CANCER, 2017, 103 : S53 - S54
  • [16] Stereotactic ablative radiotherapy for oligometastatic non-small cell lung cancer
    Verma, Vivek
    Chang, Joe Y.
    JOURNAL OF THORACIC DISEASE, 2018, 10 (01) : 21 - 24
  • [17] Endoscopic nodal staging in oligometastatic non-small cell lung cancer (NSCLC) being treated with stereotactic ablative radiotherapy (ENDO-SABR)
    Inderdeep Dhaliwal
    Shayan Kassirian
    Michael A. Mitchell
    Mehdi Qiabi
    Andrew Warner
    Alexander V. Louie
    Harvey H. Wong
    Christine M. McDonald
    Jason Rajchgot
    David A. Palma
    BMC Cancer, 22
  • [18] Experience of stereotactic ablative radiotherapy (SABR) in early stage non-small cell lung cancer (NSCLC): an analysis of treatment response and survival outcome
    Iqbal, M. S.
    Pickles, R.
    Mackenzie, L.
    Burns, A.
    Turnbull, H.
    Atherton, P.
    LUNG CANCER, 2019, 127 : S73 - S73
  • [19] Impact of Facility Treatment Volume on Stereotactic Ablative Radiotherapy (SABR) Outcomes in Early-Stage Non-Small Cell Lung Cancer (NSCLC)
    Marar, M.
    Bryant, A. K.
    Nalawade, V.
    Das, M.
    Loo, B. W., Jr.
    Diehn, M.
    Chin, A. L.
    Murphy, J. D.
    Vitzthum, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E447 - E447
  • [20] Endoscopic nodal staging in oligometastatic non-small cell lung cancer (NSCLC) being treated with stereotactic ablative radiotherapy (ENDO-SABR)
    Dhaliwal, Inderdeep
    Kassirian, Shayan
    Mitchell, Michael A.
    Qiabi, Mehdi
    Warner, Andrew
    Louie, Alexander, V
    Wong, Harvey H.
    McDonald, Christine M.
    Rajchgot, Jason
    Palma, David A.
    BMC CANCER, 2022, 22 (01)
12345